Yeji Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yeji Kim has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Inbo Han
Department of Neurosurgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
3 shared publications - Chanyoung Song
Department of Biomedical Informatics, CHA University School of Medicine, Bundang-gu, Seongnam-si 13488, Republic of Korea
1 shared publication - Dong-Youn Hwang
Department of Biomedical Science, Graduate School of CHA University, Seongnam-si, Republic of Korea
1 shared publication - Gyuseon Song
Department of Biomedical Informatics, CHA University School of Medicine, Bundang-gu, Seongnam-si 13488, Republic of Korea
1 shared publication - Hae Eun Shin
Department of Neurosurgery, CHA Bundang Medical Center, CHA University, Seongnam-si 13496, Republic of Korea
1 shared publication - Hyun-Wook Han
Department of Biomedical Informatics, CHA University School of Medicine, Bundang-gu, Seongnam-si 13488, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 23 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 2079
Extracellular Vesicle-Based Biomarkers in Spinal Cord Injury: A State-of-the-Art Review on Diagnostic and Prognostic Advances
Spinal cord injury (SCI) is a devastating neurological disorder that can result in permanent disability and reduced quality of life, characterized by heterogeneous injury mechanisms and limited tools for accurate early diagnosis and prognostic stratification. The clinical course of SCI is driven not only by the initial mechanical insult but also by complex secondary injury cascades involving neuroinflammation, axonal degeneration, demyelination, and maladaptive repair responses. Current diagnostic and prognostic approaches, which rely largely on neurological examination and imaging, provide limited insight into these dynamic molecular processes. In this context, extracellular vesicles (EVs) have emerged as a biologically compelling source of biomarkers for SCI. EVs are released by neurons, glial cells, endothelial cells, and immune cells and carry molecular cargo that reflects cellular stress, injury severity, and endogenous repair activity. Increasing evidence indicates that EV-associated proteins and regulatory microRNAs (miRNAs) encode injury-specific signatures related to neuronal and glial damage, inflammatory signaling, metabolic stress, and functional recovery potential. In this review, we summarize the current knowledge on EV biology in SCI and discuss emerging evidence supporting EV-derived proteins and miRNAs as promising tools for refining diagnosis and prognosis. Our aim is not only to consolidate established findings but also to highlight EV-based molecular signatures as a developing framework for precision biomarker discovery in SCI.
- 23 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 2079
Open AccessExtracellular Vesicle-Based Biomarkers in Spinal Cord Injury: A State-of-the-Art Review on Diagnostic and Prognostic Advances
Spinal cord injury (SCI) is a devastating neurological disorder that can result in permanent disability and reduced quality of life, characterized by heterogeneous injury mechanisms and limited tools for accurate early diagnosis and prognostic stratification. The clinical course of SCI is driven not only by the initial mechanical insult but also by complex secondary injury cascades involving neuroinflammation, axonal degeneration, demyelination, and maladaptive repair responses. Current diagnostic and prognostic approaches, which rely largely on neurological examination and imaging, provide limited insight into these dynamic molecular processes. In this context, extracellular vesicles (EVs) have emerged as a biologically compelling source of biomarkers for SCI. EVs are released by neurons, glial cells, endothelial cells, and immune cells and carry molecular cargo that reflects cellular stress, injury severity, and endogenous repair activity. Increasing evidence indicates that EV-associated proteins and regulatory microRNAs (miRNAs) encode injury-specific signatures related to neuronal and glial damage, inflammatory signaling, metabolic stress, and functional recovery potential. In this review, we summarize the current knowledge on EV biology in SCI and discuss emerging evidence supporting EV-derived proteins and miRNAs as promising tools for refining diagnosis and prognosis. Our aim is not only to consolidate established findings but also to highlight EV-based molecular signatures as a developing framework for precision biomarker discovery in SCI.
- Open Access
- 7 November 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (22) , 16024
Enhanced Intervertebral Disc Repair via Genetically Engineered Mesenchymal Stem Cells with Tetracycline Regulatory System
The therapeutic potential of Mesenchymal stem cells (MSCs) for the treatment of Intervertebral disc (IVD) degeneration can be enhanced by amplifying specific cytokines and proteins. This study aimed to investigate the therapeutic potential of tetracycline-off system-engineered tonsil-derived mesenchymal stem cells (ToMSC-Tetoff-TGFβ1-IGF1-BMP7) for treating intervertebral disc (IVD) degeneration. ToMSCs were isolated from a tonsillectomy patient and genetically modified with four distinct plasmids via CRISPR/Cas9-mediated knock-in gene editing. Transgene expression was confirmed through immunofluorescence, western blots, and an enzyme-linked immunosorbent assay for transforming growth factor beta 1 (TGFβ1) protein secretion, and the effect of MSC-TetOff-TGFβ1-IGF1-BMP7 on disc injury was assessed in a rat model. The ToMSC-Tetoff-TGFβ1-IGF1-BMP7 treatment exhibited superior therapeutic effects compared to ToMSC-TGFβ1, and ToMSC-SDF1α implantation groups, stimulating the regeneration of nucleus pulposus (NP) cells crucial for IVD. The treatment showed potential to restore the structural integrity of the extracellular matrix (ECM) by upregulating key molecules such as aggrecan and type II collagen. It also exhibited anti-inflammatory properties and reduced pain-inducing neuropeptides. ToMSC-Tetoff-TGFβ1-IGF1-BMP7 holds promise as a novel treatment for IVD degeneration. It appears to promote NP cell regeneration, restore ECM structure, suppress inflammation, and reduce pain. However, more research and clinical trials are required to confirm its therapeutic potential.
- 7 November 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (22) , 16024
Open AccessEnhanced Intervertebral Disc Repair via Genetically Engineered Mesenchymal Stem Cells with Tetracycline Regulatory System
The therapeutic potential of Mesenchymal stem cells (MSCs) for the treatment of Intervertebral disc (IVD) degeneration can be enhanced by amplifying specific cytokines and proteins. This study aimed to investigate the therapeutic potential of tetracycline-off system-engineered tonsil-derived mesenchymal stem cells (ToMSC-Tetoff-TGFβ1-IGF1-BMP7) for treating intervertebral disc (IVD) degeneration. ToMSCs were isolated from a tonsillectomy patient and genetically modified with four distinct plasmids via CRISPR/Cas9-mediated knock-in gene editing. Transgene expression was confirmed through immunofluorescence, western blots, and an enzyme-linked immunosorbent assay for transforming growth factor beta 1 (TGFβ1) protein secretion, and the effect of MSC-TetOff-TGFβ1-IGF1-BMP7 on disc injury was assessed in a rat model. The ToMSC-Tetoff-TGFβ1-IGF1-BMP7 treatment exhibited superior therapeutic effects compared to ToMSC-TGFβ1, and ToMSC-SDF1α implantation groups, stimulating the regeneration of nucleus pulposus (NP) cells crucial for IVD. The treatment showed potential to restore the structural integrity of the extracellular matrix (ECM) by upregulating key molecules such as aggrecan and type II collagen. It also exhibited anti-inflammatory properties and reduced pain-inducing neuropeptides. ToMSC-Tetoff-TGFβ1-IGF1-BMP7 holds promise as a novel treatment for IVD degeneration. It appears to promote NP cell regeneration, restore ECM structure, suppress inflammation, and reduce pain. However, more research and clinical trials are required to confirm its therapeutic potential.
- Open Access
- 7 December 2022
- Published by MDPI AG in Applied Sciences
- Vol. 12 (24) , 12521
Using Natural Language Processing to Identify Low Back Pain in Imaging Reports
A natural language processing (NLP) pipeline was developed to identify lumbar spine imaging findings associated with low back pain (LBP) in X-radiation (X-ray), computed tomography (CT), and magnetic resonance imaging (MRI) reports. A total of 18,640 report datasets were randomly sampled (stratified by imaging modality) to obtain a balanced sample of 300 X-ray, 300 CT, and 300 MRI reports. A total of 23 radiologic findings potentially related to LBP were defined, and their presence was extracted from radiologic reports. In developing NLP pipelines, section and sentence segmentation from the radiology reports was performed using a rule-based method, including regular expression with negation detection. Datasets were randomly split into 80% for development and 20% for testing to evaluate the model’s extraction performance. The performance of the NLP pipeline was evaluated by using recall, precision, accuracy, and the F1 score. In evaluating NLP model performances, four parameters—recall, precision, accuracy, and F1 score—were greater than 0.9 for all 23 radiologic findings. These four scores were 1.0 for 10 radiologic findings (listhesis, annular fissure, disc bulge, disc extrusion, disc protrusion, endplate edema or Type 1 Modic change, lateral recess stenosis, Schmorl’s node, osteophyte, and any stenosis). In the seven potentially clinically important radiologic findings, the F1 score ranged from 0.9882 to 1.0. In this study, a rule-based NLP system identifying 23 findings related to LBP from X-ray, CT, and MRI reports was developed, and it presented good performance in regards to the four scoring parameters.
- 7 December 2022
- Published by MDPI AG in Applied Sciences
- Vol. 12 (24) , 12521
Open AccessUsing Natural Language Processing to Identify Low Back Pain in Imaging Reports
A natural language processing (NLP) pipeline was developed to identify lumbar spine imaging findings associated with low back pain (LBP) in X-radiation (X-ray), computed tomography (CT), and magnetic resonance imaging (MRI) reports. A total of 18,640 report datasets were randomly sampled (stratified by imaging modality) to obtain a balanced sample of 300 X-ray, 300 CT, and 300 MRI reports. A total of 23 radiologic findings potentially related to LBP were defined, and their presence was extracted from radiologic reports. In developing NLP pipelines, section and sentence segmentation from the radiology reports was performed using a rule-based method, including regular expression with negation detection. Datasets were randomly split into 80% for development and 20% for testing to evaluate the model’s extraction performance. The performance of the NLP pipeline was evaluated by using recall, precision, accuracy, and the F1 score. In evaluating NLP model performances, four parameters—recall, precision, accuracy, and F1 score—were greater than 0.9 for all 23 radiologic findings. These four scores were 1.0 for 10 radiologic findings (listhesis, annular fissure, disc bulge, disc extrusion, disc protrusion, endplate edema or Type 1 Modic change, lateral recess stenosis, Schmorl’s node, osteophyte, and any stenosis). In the seven potentially clinically important radiologic findings, the F1 score ranged from 0.9882 to 1.0. In this study, a rule-based NLP system identifying 23 findings related to LBP from X-ray, CT, and MRI reports was developed, and it presented good performance in regards to the four scoring parameters.